Evommune, Inc.(EVMN)

$13.67—

Chart

Evommune, Inc.(EVMN)

NYSE

$13.67—

Chart Studio

EVMN(EVMN)

EVMN

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.82

Oct 16, 2026

Revenue Estimate

$500,000

Analyst Sentiment

Wall St. Consensus

Buy

4 analysts·Low coverage

Score

2 Buy (50%)2 Hold (50%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

250%

Hold

250%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$26.00

+90.2%

Consensus

$38.00

+178.0%

Bull

$50.00

+265.8%

12-Month Target Range4 analysts

$26.00$38.00$50.00

Current $13.67Consensus

Current Price

$13.67

Upside to Consensus

$24.33

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-69.70%

EPS—

FY2028

Rev+60.00%

EPS—

FY2029

Rev+212.50%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$4M	$1M	$2M	$6M	$49M
Low	$4M	$1M	$2M	$6M	$49M
High	$4M	$1M	$2M	$6M	$49M
EBITDA Avg	$-4M	$-1M	$-2M	$-6M	$-49M
Low	$-4M	$-1M	$-2M	$-6M	$-49M
High	$-4M	$-1M	$-2M	$-6M	$-49M
EBIT Avg	$-4M	$-1M	$-2M	$-6M	$-49M
Low	$-4M	$-1M	$-2M	$-6M	$-49M
High	$-4M	$-1M	$-2M	$-6M	$-49M
Net Income Avg	$-116M	$-101M	$-109M	$-133M	$-120M
Low	$-122M	$-132M	$-133M	$-133M	$-120M
High	$-93M	$-71M	$-85M	$-133M	$-120M
EPS Avg	$-3.38	$-3.44	$-3.57	$-4.21	$-3.79
Low	$-3.86	$-4.18	$-4.21	$-4.21	$-3.79
High	$-2.96	$-2.24	$-2.69	$-4.21	$-3.79
Analysts (Rev / EPS)	5 / 8	5 / 8	5 / 4	2 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$500,000	$4M	—	—	—	—	—	—
Low	$500,000	$4M	—	—	—	—	—	—
High	$500,000	$4M	—	—	—	—	—	—
EBITDA Avg	$-500,000	$-4M	—	—	—	—	—	—
Low	$-500,000	$-4M	—	—	—	—	—	—
High	$-500,000	$-4M	—	—	—	—	—	—
EBIT Avg	$-500,000	$-4M	—	—	—	—	—	—
Low	$-500,000	$-4M	—	—	—	—	—	—
High	$-500,000	$-4M	—	—	—	—	—	—
Net Income Avg	$-30M	$-30M	$-33M	$-35M	$-36M	$-38M	$-31M	$-31M
Low	$-37M	$-37M	$-33M	$-35M	$-36M	$-38M	$-31M	$-31M
High	$-24M	$-23M	$-33M	$-35M	$-36M	$-38M	$-31M	$-31M
EPS Avg	$-0.83	$-0.83	$-0.93	$-0.96	$-1.00	$-1.06	$-0.86	$-0.86
Low	$-1.02	$-1.02	$-0.93	$-0.96	$-1.00	$-1.06	$-0.86	$-0.86
High	$-0.68	$-0.64	$-0.93	$-0.96	$-1.00	$-1.06	$-0.86	$-0.86
Analysts (Rev / EPS)	4 / 7	4 / 7	— / 2	— / 2	— / 2	— / 5	— / 6	— / 5

Earnings Surprises

Recent Analyst Actions

Jun 30, 2026Morgan Stanley

Evommune price target lowered to $26 from $55 at Morgan Stanley

Target:$26.00

+72.8%from $15.05

May 26, 2026H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Evommune Inc (EVMN)

Target:$50.00

+118.6%from $22.87

May 11, 2026Morgan Stanley

Evommune price target raised to $55 from $54 at Morgan Stanley

Target:$55.00

+124.5%from $24.50

Feb 18, 2026Morgan Stanley

Evommune price target raised to $54 from $36 at Morgan Stanley

Target:$54.00

+73.9%from $31.06

Feb 10, 2026Evercore ISI

Evommune price target raised to $55 from $40 at Evercore ISI

Target:$55.00

+82.7%from $30.10

Feb 10, 2026H.C. Wainwright

Evommune price target raised to $65 from $35 at H.C. Wainwright

Target:$65.00

+125.6%from $28.81

Jan 22, 2026Oppenheimer

Evommune initiated with an Outperform at Oppenheimer

Target:$42.00

+127.3%from $18.48

Jan 7, 2026Raymond James

Evommune initiated with a Strong Buy at Raymond James

Target:$40.00

+146.9%from $16.20

Jan 6, 2026H.C. Wainwright

Evommune initiated with a Buy at H.C. Wainwright

Target:$35.00

+127.7%from $15.37

Dec 1, 2025Leerink Partners

Evommune initiated with an Outperform at Leerink

Target:$42.00

+102.8%from $20.71

Dec 1, 2025Evercore ISI

Evommune initiated with an Outperform at Evercore ISI

Target:$40.00

+93.1%from $20.71

Dec 1, 2025Morgan Stanley

Evommune initiated with an Overweight at Morgan Stanley

Target:$36.00

+73.8%from $20.71

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance